BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GeneGo, Inc. and Omicsoft Corporation Collaborate on Pathway Analysis for Next Generation Sequence Data


9/29/2010 8:53:41 AM

ST. JOSEPH, Mich., Sept. 29 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company and Omicsoft Corporation, the leader in the OMIC repository and analysis field, announced today integration of Omicsoft's Next Generation Sequencing tools with GeneGo's MetaCore data mining suite.

Array Studio, Omicsoft's software package that provides state of the art statistics analysis and visualization tools for high dimensional quantification data (OMICS data), also supports analysis of Next Generation Sequencing Data (both RNA-Seq and DNA-Seq). Omicsoft has developed high performance proprietary sequence alignment algorithms for the major NGS platforms, i.e. Illumina's Solexa, Roche's 454 and SOLID from Life Technologies. Array Studio fully supports known and novel exon junction detection, fusion gene detection (both single end and paired end), expression value calculation, along with mutation reporting/annotation and more, all in one easy-to-use software package which provide complete analysis from machine-generated sequence runs to the lists of modified genes and polymorphisms.

Array Studio is seamlessly integrated with GeneGo's data mining suites MetaCore and MetaDrug, allowing in depth analysis of the users NGS data.

"Omicsoft is delighted to continue its partnership with GeneGo, as the OMICs field enters a new era with next generation sequencing technology. We feel that our alignment algorithm, coupled with our industry leading visualization and statistical package Array Studio, will allow us to continue to pave the way in the OMICs industry. The extra benefits provided by NGS platforms, for instance, detection of gene fusion, will play a key role in biomarker discovery in cancer genomics. Integration with GeneGo's platforms is key to this success, through their tools for systems biology," said Jack Liu, President of Omicsoft.

"We are happy to extend our long-term collaboration with Omicsoft into next-generation sequencing," said Julie Bryant, GeneGo's VP of Business development. "NGS technologies provide the richest content data in life sciences, and we believe that they have one of the most comprehensive solutions. Pathway and network analysis is a natural next step for these complex data, and we are glad that we can provide our customers with a seamlessly integrated workflows from raw sequence data to biologically meaningful hypotheses on biomarkers, drug targets and drug repositioning."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 6.3, assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 6.3 is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.

SOURCE GeneGo, Inc.


Read at BioSpace.com

Related News

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->